Pipeline Progresses at Glaxo/THRX – InvestorIdeas.com (press release)


InPharm

Pipeline Progresses at Glaxo/THRX
InvestorIdeas.com (press release)
In the EU, a regulatory application for asthma was also submitted. The COPD application in the US relates to the approval of Breo as long-term maintenance treatment of airflow obstruction in COPD patients, including chronic bronchitis and/or emphysema
GSK and Theravance file for FF/VI approval in the USA and Europe; Talks with The Pharma Letter
GSK, Theravance seek approvals for FF/VI in US, EuropePharmaceutical Business Review
GSK and Theravance file COPD drugInPharm
Pharma Times
all 5 news articles »

View full post on asthma – Google News